Skip to main content
Log in

Weight gain associated with clozapine, olanzapine and risperidone in children and adolescents

  • Published:
Journal of Neural Transmission Aims and scope Submit manuscript

Summary.

The study was aimed at the evaluation of weight gain associated with atypical antipsychotics and its clinical risk factors in children and adolescents. Weight and body mass index (BMI) of initially hospitalised patients treated with clozapine (n = 15), olanzapine (n = 15), and risperidone (n = 15) were prospectively monitored on a weekly basis for the first 6 weeks. Different clinical risk factors were tested for their association with weight gain in the three groups. All three groups experienced significant weight gain between baseline and endpoint (p < 0.0001). For all weight measures, planned comparisons were all significant between olanzapine vs. clozapine and risperidone, respectively. Average weight gain was significantly higher for the olanzapine group (mean = 4.6 kg, SD = 1.9) than for the risperidone (mean = 2.8 kg, SD = 1.3) and clozapine (mean = 2.5 kg, SD = 2.9) groups. Olanzapine and risperidone, but not clozapine, caused a disproportionately higher weight gain in children and adolescents in comparison to adults.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • DB Allison JL Mentore M Heo LP Chandler JC Cappelleri MC Infante PJ Weiden (1999) ArticleTitleAntipsychotic-induced weight gain: a comprehensive research synthesis Am J Psychiatry 156 1686–1696 Occurrence Handle10553730 Occurrence Handle1:STN:280:DC%2BD3c%2FhvFWmug%3D%3D

    PubMed  CAS  Google Scholar 

  • MG Aman G De Smedt A Derivan B Lyons RL Findling (2002) ArticleTitleDouble-blind, placebo-controlled study of risperidone for the treatment of disruptive behaviors in children with subaverage intelligence Am J Psychiatry 159 1337–1346 Occurrence Handle12153826 Occurrence Handle10.1176/appi.ajp.159.8.1337

    Article  PubMed  Google Scholar 

  • KT Brady (1989) ArticleTitleWeight gain associated with psychotropic drugs South Med J 82 611–617 Occurrence Handle2566204 Occurrence Handle1:STN:280:DyaL1M3kt1ahtA%3D%3D

    PubMed  CAS  Google Scholar 

  • JK Buitelaar (2000) ArticleTitleOpen-label treatment with risperidone of 26 psychiatrically-hospitalized children and adolecents with mixed diagnoses and aggressive behavior J Child Adolesc Psychopharmacol 10 19–26 Occurrence Handle10755578 Occurrence Handle1:STN:280:DC%2BD3c3hs1emtg%3D%3D

    PubMed  CAS  Google Scholar 

  • JK Buitelaar RJ van der Gaag P Cohen-Kettenis CT Melman (2001) ArticleTitleA randomized controlled trial of risperidone in the treatment of aggression in hospitalized adolescents with subaverage cognitive abilities J Clin Psychiatry 62 IssueID4 239–248 Occurrence Handle11379837 Occurrence Handle1:CAS:528:DC%2BD3MXkt1CmsL4%3D Occurrence Handle10.4088/JCP.v62n0405

    Article  PubMed  CAS  Google Scholar 

  • Cohen J (1988) Statistical power analysis for the behavioral sciences. Erlbaum, Hillsdale

  • TJ Cole (1990) ArticleTitleThe LMS method for constructing normalized growth standards Eur J Clin Nutr 44 45–60 Occurrence Handle2354692 Occurrence Handle1:STN:280:DyaK3c3osVCksQ%3D%3D

    PubMed  CAS  Google Scholar 

  • RL Findling NK McNamara LA Branicky MD Schluchter E Lemon JL Blumer (2000) ArticleTitleA double-blind pilot study of risperidone in the treatment of conduct disorder J Am Acad Child Adolesc Psychiatry 39 509–516 Occurrence Handle10761354 Occurrence Handle10.1097/00004583-200004000-00021 Occurrence Handle1:STN:280:DC%2BD3c3isVChsg%3D%3D

    Article  PubMed  CAS  Google Scholar 

  • C Fleischhaker E Schulz H Remschmidt (1998) ArticleTitleBiogenic amines as predictors of response to clozapine treatment in early-onset schizophrenia J Psychiatr Res 32 325–333 Occurrence Handle9789212 Occurrence Handle10.1016/S0022-3956(98)00012-0 Occurrence Handle1:STN:280:DyaK1M%2FgsFKnsw%3D%3D

    Article  PubMed  CAS  Google Scholar 

  • JA Frazier CT Gordon K McKenna MC Lenane D Jih JL Rapaport (1994) ArticleTitleAn open trial of clozapine adolescents with childhood-onset schizophrenia J Am Acad Child Adolesc Psychiatry 33 658–663 Occurrence Handle8056728 Occurrence Handle10.1097/00004583-199406000-00006 Occurrence Handle1:STN:280:DyaK2czjsVamtg%3D%3D

    Article  PubMed  CAS  Google Scholar 

  • D Gothelf A Apter J Reidman A Brand-Gothelf Y Bloch G Gal L Kikinzon S Tyano R Weizman G Ratzoni (2003) ArticleTitleOlanzapine, risperidone and haloperidol in the treatment of adolescent patients with schizophrenia J Neural Transm 110 545–560 Occurrence Handle12721815 Occurrence Handle10.1007/s00702-002-0803-7 Occurrence Handle1:CAS:528:DC%2BD3sXjt1Omu78%3D

    Article  PubMed  CAS  Google Scholar 

  • W Guy (1976) ECDEU assessment manual National Institute of Mental Health Rockville, MD

    Google Scholar 

  • R Kant R Chalansani KN Chengappa (2002) ArticleTitleThe use of clozapine in adolescents with diagnoses other than schizophrenia J Child Adolesc Psychopharmacol 12 290–291

    Google Scholar 

  • A Klimke E Klieser (1995) ArticleTitleThe atypical neuroleptic clozapine (Leponex) – current knowledge and recent clinical aspects Fortschr Neurol Psychiatr 63 173–193 Occurrence Handle7782019 Occurrence Handle1:STN:280:DyaK2MzgtFahtA%3D%3D

    PubMed  CAS  Google Scholar 

  • K Kromeyer-Hauschild M Wabitsch D Kunze F Geller HC Geiß V Hesse A von Hippel U Jaeger D Johnsen W Korte K Menner G Müller JM Müller A Niemann-Pilatus T Remer F Schaefer HU Wittchen S Zabransky K Zellner A Ziegler J Hebebrand (2001) ArticleTitlePerzentile für den Body-mass-Index für das Kindes- und Jugendalter unter Heranziehung verschiedener deutscher Stichproben Monatsschr Kinderheilkde 149 807–818 Occurrence Handle10.1007/s001120170107

    Article  Google Scholar 

  • S Kumra JA Frazier LK Jacobsen K McKenna CT Gordon MC Lenane SD Hamburger AK Smith KE Albus J Alaghbandrad JL Rapoport (1996) ArticleTitleChildhood-onset schizophrenia – a double-blind clozapine-haloperidol comparison Arch Gen Psychiatry 53 1090–1097 Occurrence Handle8956674 Occurrence Handle1:STN:280:DyaK2s7hsFaksQ%3D%3D

    PubMed  CAS  Google Scholar 

  • S Kumra LK Jacobsen M Lenane BI Karp JA Frazier AK Smith J Bedwell P Lee CJ Malanga S Hamburger JL Rapoport (1998) ArticleTitleChildhood-onset schizophrenia: an open-label study of olanzapine in adolescents J Am Acad Child Adolesc Psychiatry 37 377–385 Occurrence Handle9549958 Occurrence Handle10.1097/00004583-199804000-00015 Occurrence Handle1:STN:280:DyaK1c3htFWhug%3D%3D

    Article  PubMed  CAS  Google Scholar 

  • R Leadbetter M Shutty D Pavalonis V Vieweg P Higgins M Downs (1992) ArticleTitleClozapine-induced weight gain: prevalence and clinical relevance Am J Psychiatry 149 68–72 Occurrence Handle1728188 Occurrence Handle1:STN:280:DyaK38%2FpsFCjtw%3D%3D

    PubMed  CAS  Google Scholar 

  • PJ Lombroso (1996) ArticleTitleRisperidone treatment of children and adolescents with chronic tic disorders: a preliminary report J Am Acad Child Adolesc Psychiatry 35 394

    Google Scholar 

  • SQ Luo ET Li (1991) ArticleTitleEffects of rapid administration of serotonergic agonists on diet selection and body weight in rats Pharmacol Biochem Behav 38 495–500 Occurrence Handle2068186 Occurrence Handle10.1016/0091-3057(91)90003-K Occurrence Handle1:CAS:528:DyaK3MXhslyrtLY%3D

    Article  PubMed  CAS  Google Scholar 

  • SR Marder SM Essock AL Miller RW Buchanan DE Casey JM Davis JM Kane JA Lieberman NR Schooler N Covell S Stroup EM Weissman DA Wirshing CS Hall L Pogach FX Pi-Sunyer JT Bigger A Friedman D Kleinberg SJ Yevich B Davis LR Shone (2004) ArticleTitlePhysical health monitoring of patients with schizophrenia Am J Psychiatry 161 1334–1349 Occurrence Handle15285957 Occurrence Handle10.1176/appi.ajp.161.8.1334

    Article  PubMed  Google Scholar 

  • G Masi A Cosenza M Mucci P Brovedani (2001) ArticleTitleOpen trial of risperidone in 24 young children with pervasive developmental disorders J Am Acad Child Adolesc Psychiatry 40 1206–1214 Occurrence Handle11589534 Occurrence Handle10.1097/00004583-200110000-00015 Occurrence Handle1:STN:280:DC%2BD3Mrkt1eltA%3D%3D

    Article  PubMed  CAS  Google Scholar 

  • D Michelson JD Amsterdam FM Quitkin FW Reimherr JF Rosenbaum JM Zajecka KL Sundell Y Kim CM Beasley SuffixJr (1999) ArticleTitleChanges in weight during a 1-year trial of fluoxetine Am J Psychiatry 156 1170–1176 Occurrence Handle10450256 Occurrence Handle1:STN:280:DyaK1MznvVOmsg%3D%3D

    PubMed  CAS  Google Scholar 

  • S Mukherjee P Decina V Bocola F Saraceni PL Scapicchio (1996) ArticleTitleDiabetis mellitus in schizophrenic patients Compr Psychiatry 37 68–73 Occurrence Handle8770530 Occurrence Handle10.1016/S0010-440X(96)90054-1 Occurrence Handle1:STN:280:DyaK28zms1emsQ%3D%3D

    Article  PubMed  CAS  Google Scholar 

  • DL Murphy C Wichems Q Li (1999) ArticleTitleMolecular manipulations as tools for enhancing our understanding of 5-HT neurotransmission Trends Pharmacol Sci 20 246–252 Occurrence Handle10366867 Occurrence Handle10.1016/S0165-6147(99)01325-5 Occurrence Handle1:CAS:528:DyaK1MXksVentLg%3D

    Article  PubMed  CAS  Google Scholar 

  • FX Pi-Sunyer (1993) ArticleTitleMedical hazards of obesity Ann Intern Med 119 655–660 Occurrence Handle8363192 Occurrence Handle1:STN:280:DyaK3szntVyitw%3D%3D

    PubMed  CAS  Google Scholar 

  • MN Potenza JP Holmes SJ Kanes CJ McDougle (1999) ArticleTitleOlanzapine treatment of children, adolescents, and adults with pervasive developmental disorders: an open-label pilot study J Clin Psychopharmacol 19 37–44 Occurrence Handle9934941 Occurrence Handle10.1097/00004714-199902000-00008 Occurrence Handle1:CAS:528:DyaK1MXpvV2qtw%3D%3D

    Article  PubMed  CAS  Google Scholar 

  • M Prendergast (1992) ArticleTitleDrug Treatment Arch Dis Child 67 1488–1494 Occurrence Handle1489231 Occurrence Handle1:STN:280:DyaK3s7ktleqsA%3D%3D Occurrence Handle10.1136/adc.67.12.1488

    Article  PubMed  CAS  Google Scholar 

  • G Ratzoni D Gothelf A Brand-Gothelf J Reidman L Kikinzon G Gal M Phillip A Apter R Weizman (2002) ArticleTitleWeight gain associated with olanzapine and risperidone in adolescent patients: a comparative prospective study J Am Acad Child Adolesc Psychiatry 41 337–343 Occurrence Handle11886029 Occurrence Handle10.1097/00004583-200203000-00014

    Article  PubMed  Google Scholar 

  • H Remschmidt K Hennighausen HW Clement P Heiser E Schulz (2000) ArticleTitleAtypical neuroleptics in child and adolescent psychiatry Eur Child Adolesc Psychiatry 9 IssueIDSuppl 1 9–19 Occurrence Handle10.1007/s007870070015

    Article  Google Scholar 

  • RA Rison PK Stanton (1995) ArticleTitleLong-term potentiation and N-methyl-d-aspartate receptors: foundations of memory and neurologic disease? Neurosci Biobehav Rev 19 533–552 Occurrence Handle8684715 Occurrence Handle10.1016/0149-7634(95)00017-8 Occurrence Handle1:CAS:528:DyaK28XktlOltQ%3D%3D

    Article  PubMed  CAS  Google Scholar 

  • WJ Rockwell EH Ellinwood DW Trader (1983) ArticleTitlePsychotropic drugs promoting weight gain: health risks and treatment implications South Med J 76 1407–1412 Occurrence Handle6138860 Occurrence Handle1:STN:280:DyaL2c%2FksV2msw%3D%3D

    PubMed  CAS  Google Scholar 

  • RG Ross DK Novins GK Farley LE Adler (2003) ArticleTitleA 1-year open-label trial of olanzapine in school-age children with schizophrenia J Child Adolesc Psychopharmacol 13 301–309 Occurrence Handle14642018 Occurrence Handle10.1089/104454603322572633

    Article  PubMed  Google Scholar 

  • R Samanin S Garattini (1990) The pharmacology of serotonergic drugs affecting appetite RJ Wurtman JJ Wurtman (Eds) Nutrition and the brain Raven Press New York 163–192

    Google Scholar 

  • EH Sholevar DA Baron TL Hardie (2000) ArticleTitleTreatment of childhood-onset schizophrenia with olanzapine J Child Adolesc Psychopharmacol 10 69–78 Occurrence Handle10933117 Occurrence Handle1:STN:280:DC%2BD3M%2FotFOhsg%3D%3D

    PubMed  CAS  Google Scholar 

  • L Sikich RM Hamer RA Bashford BB Sheitman JA Lieberman (2004) ArticleTitleA pilot study of risperidone, olanzapine, and haloperidol in psychotic youth: a double-blind, randomized, 8-week trial Neuropsychopharmacology 29 133–145 Occurrence Handle14583740 Occurrence Handle10.1038/sj.npp.1300327 Occurrence Handle1:CAS:528:DC%2BD3sXhtVSqsL7I

    Article  PubMed  CAS  Google Scholar 

  • LH Tecott LM Sun SF Akana (1995) ArticleTitleEating disorder and epilepsy in mice lacking 5-HT-2c serotonin receptors Nature 374 542–546 Occurrence Handle7700379 Occurrence Handle10.1038/374542a0 Occurrence Handle1:CAS:528:DyaK2MXkvVKqtr4%3D

    Article  PubMed  CAS  Google Scholar 

  • DA Wirshing (2004) ArticleTitleSchizophrenia and obesity: impact of antipsychotic medications J Clin Psychiatry 65 13–26 Occurrence Handle15600381

    PubMed  Google Scholar 

  • DA Wirshing JA Loyd LR Meng JS Ballon SR Marder WC Wirshing (2002) ArticleTitleThe effects of novel antipsychotics on glucose and lipid levels J Clin Psychiatry 63 856–865 Occurrence Handle12416594 Occurrence Handle1:CAS:528:DC%2BD38Xosl2qsLc%3D

    PubMed  CAS  Google Scholar 

  • DA Wirshing WC Wirshing L Kysar MA Berisford D Goldstein J Pashdag J Mintz SR Marder (1999) ArticleTitleNovel antipsychotics: comparison of weight gain liabilities J Clin Psychiatry 60 358–363 Occurrence Handle10401912 Occurrence Handle1:CAS:528:DyaK1MXktlegsLY%3D

    PubMed  CAS  Google Scholar 

  • G Zalsman H Carnahan A Martin D Bensason A Weizman S Tyano (2003) ArticleTitleEffectiveness, safety, and tolerability of risperidone in adolescents with schizophrenia: an open-lebel study J Child Adolesc Psychopharmacol 13 327 Occurrence Handle10.1089/104454603322572651

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fleischhaker, C., Heiser, P., Hennighausen, K. et al. Weight gain associated with clozapine, olanzapine and risperidone in children and adolescents. J Neural Transm 114, 273–280 (2007). https://doi.org/10.1007/s00702-006-0602-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00702-006-0602-7

Navigation